Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants

Journal of Experimental Biology

Volumn 218, Issue 1, 2015, Pages 21-31

  Duclot, Florian ^a   Kabbaj, Mohamed ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

BDNF; Epigenetics; Individual differences

Indexed keywords

ANIMALIA;

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR;

ANIMAL; DEPRESSION; DISEASE MODEL; DRUG EFFECTS; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; HUMAN;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 84926052339     PISSN: 00220949     EISSN: None     Source Type: Journal    
DOI: 10.1242/jeb.107086     Document Type: Review

References (173)

1. Abel, J. L. and Rissman, E. F. (2013). Running-induced epigenetic and gene expression changes in the adolescent brain. Int. J. Dev. Neurosci. 31, 382-390.
2. Adachi, M., Barrot, M., Autry, A. E., Theobald, D. and Monteggia, L. M. (2008). Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol. Psychiatry 63, 642-649.
3. Aid, T., Kazantseva, A., Piirsoo, M., Palm, K. and Timmusk, T. (2007). Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 85, 525-535.
4. Angelucci, F., Croce, N., Spalletta, G., Dinallo, V., Gravina, P., Bossù, P., Federici, G., Caltagirone, C. and Bernardini, S. (2011). Paroxetine rapidly modulates the expression of brain-derived neurotrophic factor mRNA and protein in a human glioblastoma-astrocytoma cell line. Pharmacology 87, 5-10.
5. Bahi, A., Chandrasekar, V. and Dreyer, J.-L. (2014). Selective lentiviral-mediated suppression of microRNA124a in the hippocampus evokes antidepressants-like effects in rats. Psychoneuroendocrinology 46, 78-87.
6. Bai, M., Zhu, X., Zhang, Y., Zhang, S., Zhang, L., Xue, L., Yi, J., Yao, S. and Zhang, X. (2012). Abnormal hippocampal BDNF and miR-16 expression is associated with depression-like behaviors induced by stress during early life. PLoS ONE 7, e46921.
7. Baj, G., D'Alessandro, V., Musazzi, L., Mallei, A., Sartori, C. R., Sciancalepore, M., Tardito, D., Langone, F., Popoli, M. and Tongiorgi, E. (2012). Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: further evidence of a spatial code for BDNF splice variants. Neuropsychopharmacology 37, 1600-1611.
8. Bath, K. G., Schilit, A. and Lee, F. S. (2013). Stress effects on BDNF expression: effects of age, sex, and form of stress. Neuroscience 239, 149-156.
9. Bebbington, P. E., Bhugra, D., Brugha, T., Singleton, N., Farrell, M., Jenkins, R., Lewis, G. and Meltzer, H. (2004). Psychosis, victimisation and childhood disadvantage: evidence from the second British National Survey of Psychiatric Morbidity. Br. J. Psychiatry 185, 220-226.
10. Béjot, Y., Mossiat, C., Giroud, M., Prigent-Tessier, A., Marie, C.; Relevance to Clinical Studies (2011). Circulating and brain BDNF levels in stroke rats. Relevance to clinical studies. PLoS ONE 6, e29405.
11. Bergström, A., Jayatissa, M. N., Mørk, A. and Wiborg, O. (2008). Stress sensitivity and resilience in the chronic mild stress rat model of depression; an in situ hybridization study. Brain Res. 1196, 41-52.
12. Berton, O. and Nestler, E. J. (2006). New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 7, 137-151.
13. Berton, O., McClung, C. A., Dileone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M. et al. (2006). Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311, 864-868.
14. Björkqvist, K. (2001). Social defeat as a stressor in humans. Physiol. Behav. 73, 435-442.
15. Blugeot, A., Rivat, C., Bouvier, E., Molet, J., Mouchard, A., Zeau, B., Bernard, C., Benoliel, J.-J. and Becker, C. (2011). Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J. Neurosci. 31, 12889-12899.
16. Bocchio-Chiavetto, L., Zanardini, R., Bortolomasi, M., Abate, M., Segala, M., Giacopuzzi, M., Riva, M. A., Marchina, E., Pasqualetti, P., Perez, J. et al. (2006). Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. Eur. Neuropsychopharmacol. 16, 620-624.
17. Bosker, F. J., Hartman, C. A., Nolte, I. M., Prins, B. P., Terpstra, P., Posthuma, D., van Veen, T., Willemsen, G., DeRijk, R. H., de Geus, E. J. et al. (2011). Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol. Psychiatry 16, 516-532.
18. Boulle, F., van den Hove, D. L. A., Jakob, S. B., Rutten, B. P., Hamon, M., van Os, J., Lesch, K. P., Lanfumey, L., Steinbusch, H. W. and Kenis, G. (2012). Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol. Psychiatry 17, 584-596.
19. Bromet, E., Andrade, L. H., Hwang, I., Sampson, N. A., Alonso, J., de Girolamo, G., de Graaf, R., Demyttenaere, K., Hu, C., Iwata, N. et al. (2011). Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 9, 90.
20. Brown, G. W., Craig, T. K. J., Harris, T. O., Herbert, J., Hodgson, K., Tansey, K. E. and Uher, R. (2014). Functional polymorphism in the brain-derived neurotrophic factor gene interacts with stressful life events but not childhood maltreatment in the etiology of depression. Depress. Anxiety 31, 326-334.
21. Brunoni, A. R., Lopes, M. and Fregni, F. (2008). A systematic review and metaanalysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 11, 1169-1180.
22. Brunoni, A. R., Kemp, A. H., Shiozawa, P., Cordeiro, Q., Valiengo, L. C. L., Goulart, A. C., Coprerski, B., Lotufo, P. A., Brunoni, D., Perez, A. B. A. et al. (2013). Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system. Eur. Neuropsychopharmacol. 23, 1530-1540.
23. Calvo, N., Cecchi, M., Kabbaj, M., Watson, S. J. and Akil, H. (2011). Differential effects of social defeat in rats with high and low locomotor response to novelty. Neuroscience 183, 81-89.
24. Castrén, E. and Rantamäki, T. (2010). The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev. Neurobiol. 70, 289-297.
25. Chase, K. A. and Sharma, R. P. (2013). Nicotine induces chromatin remodelling through decreases in the methyltransferases GLP, G9a, Setdb1 and levels of H3K9me2. Int. J. Neuropsychopharmacol. 16, 1129-1138.
26. Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F. and Young, L. T. (2001). Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50, 260-265.
27. Chen, E. S., Ernst, C. and Turecki, G. (2011). The epigenetic effects of antidepressant treatment on human prefrontal cortex BDNF expression. Int. J. Neuropsychopharmacol. 14, 427-429.
28. Choi, M.-J., Kang, R.-H., Lim, S.-W., Oh, K.-S. and Lee, M.-S. (2006). Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res. 1118, 176-182.
29. Chourbaji, S., Hellweg, R., Brandis, D., Zörner, B., Zacher, C., Lang, U. E., Henn, F. A., Hörtnagl, H. and Gass, P. (2004). Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res. Mol. Brain Res. 121, 28-36.
30. Chourbaji, S., Brandwein, C. and Gass, P. (2011). Altering BDNF expression by genetics and/or environment: impact for emotional and depression-like behaviour in laboratory mice. Neurosci. Biobehav. Rev. 35, 599-611.
31. Cleck, J. N., Ecke, L. E. and Blendy, J. A. (2008). Endocrine and gene expression changes following forced swim stress exposure during cocaine abstinence in mice. Psychopharmacology (Berl.) 201, 15-28.
32. Coppell, A. L., Pei, Q. and Zetterström, T. S. C. (2003). Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44, 903-910.
33. Coppens, C. M., Siripornmongcolchai, T., Wibrand, K., Alme, M. N., Buwalda, B., de Boer, S. F., Koolhaas, J. M. and Bramham, C. R. (2011). Social defeat during adolescence and adulthood differentially induce BDNF-regulated immediate early genes. Front. Behav. Neurosci. 5, 72.
34. Covington, H. E., III, Maze, I., LaPlant, Q. C., Vialou, V. F., Ohnishi, Y. N., Berton, O., Fass, D. M., Renthal, W., Rush, A. J., III, Wu, E. Y. et al. (2009). Antidepressant actions of histone deacetylase inhibitors. J. Neurosci. 29, 11451-11460.
35. Covington, H. E., III, Maze, I., Sun, H., Bomze, H. M., DeMaio, K. D., Wu, E. Y., Dietz, D. M., Lobo, M. K., Ghose, S., Mouzon, E. et al. (2011). A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron 71, 656-670.
36. Davies, M. N., Volta, M., Pidsley, R., Lunnon, K., Dixit, A., Lovestone, S., Coarfa, C., Harris, R. A., Milosavljevic, A., Troakes, C. et al. (2012). Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol. 13, R43.
37. de Foubert, G., Carney, S. L., Robinson, C. S., Destexhe, E. J., Tomlinson, R., Hicks, C. A., Murray, T. K., Gaillard, J. P., Deville, C., Xhenseval, V. et al. (2004). Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 128, 597-604.
38. Dreimüller, N., Schlicht, K. F., Wagner, S., Peetz, D., Borysenko, L., Hiemke, C., Lieb, K. and Tadiæ, A. (2012). Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression. Neuropharmacology 62, 264-269.
39. Duclot, F. and Kabbaj, M. (2013). Individual differences in novelty seeking predict subsequent vulnerability to social defeat through a differential epigenetic regulation of brain-derived neurotrophic factor expression. J. Neurosci. 33, 11048-11060.
40. Duclot, F., Hollis, F., Darcy, M. J. and Kabbaj, M. (2011). Individual differences in novelty-seeking behavior in rats as a model for psychosocial stress-related mood disorders. Physiol. Behav. 104, 296-305.
41. Duman, R. S. (2004a). Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med. 5, 11-25.
42. Duman, R. S. (2004b). Depression: a case of neuronal life and death? Biol. Psychiatry 56, 140-145.
43. Duman, R. S. and Monteggia, L. M. (2006). A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59, 1116-1127.
44. Duman, R. S., Heninger, G. R. and Nestler, E. J. (1997). A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54, 597-606.
45. Duman, C. H., Schlesinger, L., Russell, D. S. and Duman, R. S. (2008). Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice. Brain Res. 1199, 148-158.
46. Dwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A. and Pandey, G. N. (2003). Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 60, 804-815.
47. Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M. et al. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269.
48. Elfving, B., Plougmann, P. H., Müller, H. K., Mathé, A. A., Rosenberg, R. and Wegener, G. (2010). Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. Int. J. Neuropsychopharmacol. 13, 563-572.
49. Eng, J. J. and Reime, B. (2014). Exercise for depressive symptoms in stroke patients: a systematic review and meta-analysis. Clin. Rehabil. 28, 731-739.
50. Ernst, C., Chen, E. S. and Turecki, G. (2009a). Histone methylation and decreased expression of TrkB.T1 in orbital frontal cortex of suicide completers. Mol. Psychiatry 14, 830-832.
51. Ernst, C., Deleva, V., Deng, X., Sequeira, A., Pomarenski, A., Klempan, T., Ernst, N., Quirion, R., Gratton, A., Szyf, M. et al. (2009b). Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch. Gen. Psychiatry 66, 22-32.
52. Ewald, E. R., Wand, G. S., Seifuddin, F., Yang, X., Tamashiro, K. L., Potash, J. B., Zandi, P. and Lee, R. S. (2014). Alterations in DNA methylation of Fkbp5 as a determinant of blood-brain correlation of glucocorticoid exposure. Psychoneuroendocrinology 44, 112-122.
53. First, M., Gil-Ad, I., Taler, M., Tarasenko, I., Novak, N. and Weizman, A. (2011). The effects of fluoxetine treatment in a chronic mild stress rat model on depressionrelated behavior, brain neurotrophins and ERK expression. J. Mol. Neurosci. 45, 246-255.
54. Ford, J. D., Gelernter, J., DeVoe, J. S., Zhang, W., Weiss, R. D., Brady, K., Farrer, L. and Kranzler, H. R. (2009). Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocainedependent individuals. Drug Alcohol Depend. 99, 193-203.
55. Franklin, T. B., Saab, B. J. and Mansuy, I. M. (2012). Neural mechanisms of stress resilience and vulnerability. Neuron 75, 747-761.
56. Fuchikami, M., Yamamoto, S., Morinobu, S., Takei, S. and Yamawaki, S. (2010). Epigenetic regulation of BDNF gene in response to stress. Psychiatry Investig. 7, 251-256.
57. Fuchikami, M., Morinobu, S., Segawa, M., Okamoto, Y., Yamawaki, S., Ozaki, N., Inoue, T., Kusumi, I., Koyama, T., Tsuchiyama, K. et al. (2011). DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS ONE 6, e23881.
58. Gomez-Pinilla, F., Zhuang, Y., Feng, J., Ying, Z. and Fan, G. (2011). Exercise impacts brain-derived neurotrophic factor plasticity by engaging mechanisms of epigenetic regulation. Eur. J. Neurosci. 33, 383-390.
59. Gräff, J., Rei, D., Guan, J.-S., Wang, W.-Y., Seo, J., Hennig, K. M., Nieland, T. J. F., Fass, D. M., Kao, P. F., Kahn, M. et al. (2012). An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483, 222-226.
60. Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A. and Corey-Lisle, P. K. (2003). The economic burden of depression in the United States: how did it change between 1990 and 2000? J. Clin. Psychiatry 64, 1465-1475.
61. Guan, J.-S., Haggarty, S. J., Giacometti, E., Dannenberg, J.-H., Joseph, N., Gao, J., Nieland, T. J. F., Zhou, Y., Wang, X., Mazitschek, R. et al. (2009). HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459, 55-60.
62. Gupta-Agarwal, S., Franklin, A. V., Deramus, T., Wheelock, M., Davis, R. L., McMahon, L. L. and Lubin, F. D. (2012). G9a/GLP histone lysine dimethyltransferase complex activity in the hippocampus and the entorhinal cortex is required for gene activation and silencing during memory consolidation. J. Neurosci. 32, 5440-5453.
63. Haile, C. N., Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Foulkes, A., Iqbal, S., Mahoney, J. J. I., III, De La Garza, R., II, Charney, D. S. et al. (2014). Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int. J. Neuropsychopharmacol. 17, 331-336.
64. Halsall, J., Gupta, V., O'Neill, L. P., Turner, B. M. and Nightingale, K. P. (2012). Genes are often sheltered from the global histone hyperacetylation induced by HDAC inhibitors. PLoS ONE 7, e33453.
65. Hollis, F., Duclot, F., Gunjan, A. and Kabbaj, M. (2011). Individual differences in the effect of social defeat on anhedonia and histone acetylation in the rat hippocampus. Horm. Behav. 59, 331-337.
66. Hollis, F., Isgor, C. and Kabbaj, M. (2013). The consequences of adolescent chronic unpredictable stress exposure on brain and behavior. Neuroscience 249, 232-241.
67. Hosang, G. M., Shiles, C., Tansey, K. E., McGuffin, P. and Uher, R. (2014). Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis. BMC Med. 12, 7.
68. Hoyer, C., Kranaster, L., Sartorius, A., Hellweg, R. and Gass, P. (2012). Long-term course of brain-derived neurotrophic factor serum levels in a patient treated with deep brain stimulation of the lateral habenula. Neuropsychobiology 65, 147-152.
69. Ibarguen-Vargas, Y., Surget, A., Vourc'h, P., Leman, S., Andres, C. R., Gardier, A. M. and Belzung, C. (2009). Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress. Behav. Brain Res. 202, 245-251.
70. Intlekofer, K. A., Berchtold, N. C., Malvaez, M., Carlos, A. J., McQuown, S. C., Cunningham, M. J., Wood, M. A. and Cotman, C. W. (2013). Exercise and sodium butyrate transform a subthreshold learning event into long-term memory via a brainderived neurotrophic factor-dependent mechanism. Neuropsychopharmacology 38, 2027-2034.
71. Jha, S., Dong, B. and Sakata, K. (2011). Enriched environment treatment reverses depression-like behavior and restores reduced hippocampal neurogenesis and protein levels of brain-derived neurotrophic factor in mice lacking its expression through promoter IV. Transl. Psychiatry 1, e40.
72. Kabbaj, M., Evans, S., Watson, S. J. and Akil, H. (2004). The search for the neurobiological basis of vulnerability to drug abuse: using microarrays to investigate the role of stress and individual differences. Neuropharmacology 47 Suppl. 1, 111-122.
73. Kaffman, A. and Meaney, M. J. (2007). Neurodevelopmental sequelae of postnatal maternal care in rodents: clinical and research implications of molecular insights. J. Child Psychol. Psychiatry 48, 224-244.
74. Kang, H.-J., Kim, J.-M., Lee, J.-Y., Kim, S.-Y., Bae, K.-Y., Kim, S.-W., Shin, I.-S., Kim, H.-R., Shin, M.-G. and Yoon, J.-S. (2013). BDNF promoter methylation and suicidal behavior in depressive patients. J. Affect. Disord. 151, 679-685.
75. Karege, F., Schwald, M. and Cisse, M. (2002). Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 328, 261-264.
76. Karege, F., Bondolfi, G., Gervasoni, N., Schwald, M., Aubry, J.-M. and Bertschy, G. (2005a). Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol. Psychiatry 57, 1068-1072.
77. Karege, F., Vaudan, G., Schwald, M., Perroud, N. and La Harpe, R. (2005b). Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res. Mol. Brain Res. 136, 29-37.
78. Keller, S., Sarchiapone, M., Zarrilli, F., Videtic, A., Ferraro, A., Carli, V., Sacchetti, S., Lembo, F., Angiolillo, A., Jovanovic, N. et al. (2010). Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch. Gen. Psychiatry 67, 258-267.
79. Keller, S., Sarchiapone, M., Zarrilli, F., Tomaiuolo, R., Carli, V., Angrisano, T., Videtic, A., Amato, F., Pero, R., di Giannantonio, M. et al. (2011). TrkB gene expression and DNA methylation state in Wernicke area does not associate with suicidal behavior. J. Affect. Disord. 135, 400-404.
80. Kendler, K. S., Gatz, M., Gardner, C. O. and Pedersen, N. L. (2005). Age at onset and familial risk for major depression in a Swedish national twin sample. Psychol. Med. 35, 1573-1579.
81. Kessler, R. C. and Bromet, E. J. (2013). The epidemiology of depression across cultures. Annu. Rev. Public Health 34, 119-138.
82. Kim, J.-M., Stewart, R., Kang, H.-J., Kim, S.-Y., Kim, S.-W., Shin, I.-S., Park, M.-S., Kim, H.-R., Shin, M.-G., Cho, K.-H. et al. (2013). A longitudinal study of BDNF promoter methylation and genotype with poststroke depression. J. Affect. Disord. 149, 93-99.
83. Klein, A. B., Williamson, R., Santini, M. A., Clemmensen, C., Ettrup, A., Rios, M., Knudsen, G. M. and Aznar, S. (2011). Blood BDNF concentrations reflect braintissue BDNF levels across species. Int. J. Neuropsychopharmacol. 14, 347-353.
84. Kobayashi, K., Shimizu, E., Hashimoto, K., Mitsumori, M., Koike, K., Okamura, N., Koizumi, H., Ohgake, S., Matsuzawa, D., Zhang, L. et al. (2005). Serum brainderived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 658-663.
85. Koponen, E., Rantamäki, T., Voikar, V., Saarelainen, T., MacDonald, E. and Castrén, E. (2005). Enhanced BDNF signaling is associated with an antidepressantlike behavioral response and changes in brain monoamines. Cell. Mol. Neurobiol. 25, 973-980.
86. Koppel, I. and Timmusk, T. (2013). Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors. Neuropharmacology 75, 106-115.
87. Krishnan, V. and Nestler, E. J. (2010). Linking molecules to mood: new insight into the biology of depression. Am. J. Psychiatry 167, 1305-1320.
88. Krishnan, V. and Nestler, E. J. (2011). Animal models of depression: molecular perspectives. Curr. Top. Behav. Neurosci. 7, 121-147.
89. Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., Laplant, Q., Graham, A., Lutter, M., Lagace, D. C. et al. (2007). Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131, 391-404.
90. Kuzumaki, N., Ikegami, D., Tamura, R., Hareyama, N., Imai, S., Narita, M., Torigoe, K., Niikura, K., Takeshima, H., Ando, T. et al. (2011). Hippocampal epigenetic modification at the brain-derived neurotrophic factor gene induced by an enriched environment. Hippocampus 21, 127-132.
91. Kyeremanteng, C., James, J., Mackay, J. and Merali, Z. (2012). A study of brain and serum brain-derived neurotrophic factor protein in Wistar and Wistar-Kyoto rat strains after electroconvulsive stimulus. Pharmacopsychiatry 45, 244-249.
92. Lagace, D. C., Donovan, M. H., DeCarolis, N. A., Farnbauch, L. A., Malhotra, S., Berton, O., Nestler, E. J., Krishnan, V. and Eisch, A. J. (2010). Adult hippocampal neurogenesis is functionally important for stress-induced social avoidance. Proc. Natl. Acad. Sci. USA 107, 4436-4441.
93. LaPlant, Q., Vialou, V., Covington, H. E., 3rd, Dumitriu, D., Feng, J., Warren, B. L., Maze, I., Dietz, D. M., Watts, E. L., Iñiguez, S. D. et al. (2010). Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nat. Neurosci. 13, 1137-1143.
94. Lee, B.-H. and Kim, Y.-K. (2009). Reduced platelet BDNF level in patients with major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 849-853.
95. Li, Y.-J., Xu, M., Gao, Z.-H., Wang, Y.-Q., Yue, Z., Zhang, Y.-X., Li, X.-X., Zhang, C., Xie, S.-Y. and Wang, P.-Y. (2013). Alterations of serum levels of BDNF-related miRNAs in patients with depression. PLoS ONE 8, e63648.
96. Liu, X., Chan, C.-B., Jang, S.-W., Pradoldej, S., Huang, J., He, K., Phun, L. H., France, S., Xiao, G., Jia, Y. et al. (2010). A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect. J. Med. Chem. 53, 8274-8286.
97. Liu, R.-J., Lee, F. S., Li, X.-Y., Bambico, F., Duman, R. S. and Aghajanian, G. K. (2012). Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex. Biol. Psychiatry 71, 996-1005.
98. Lopez, J. P., Mamdani, F., Labonte, B., Beaulieu, M. M., Yang, J. P., Berlim, M. T., Ernst, C. and Turecki, G. (2013). Epigenetic regulation of BDNF expression according to antidepressant response. Mol. Psychiatry 18, 398-399.
99. Lopez, J. P., Lim, R., Cruceanu, C., Crapper, L., Fasano, C., Labonte, B., Maussion, G., Yang, J. P., Yerko, V., Vigneault, E. et al. (2014). miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nat. Med. 20, 764-768.
100. Luo, K.-R., Hong, C.-J., Liou, Y.-J., Hou, S.-J., Huang, Y.-H. and Tsai, S.-J. (2010). Differential regulation of neurotrophin S100B and BDNF in two rat models of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 34, 1433-1439.
101. Ma, Q. (2008). Beneficial effects of moderate voluntary physical exercise and its biological mechanisms on brain health. Neurosci. Bull. 24, 265-270.
102. Magni, L. R., Purgato, M., Gastaldon, C., Papola, D., Furukawa, T. A., Cipriani, A. and Barbui, C. (2013). Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst. Rev. 7, CD004185.
103. Mandelli, L. and Serretti, A. (2013). Gene environment interaction studies in depression and suicidal behavior: An update. Neurosci. Biobehav. Rev. 37, 2375-2397.
104. Martinowich, K., Manji, H. and Lu, B. (2007). New insights into BDNF function in depression and anxiety. Nat. Neurosci. 10, 1089-1093.
105. Masi, G. and Brovedani, P. (2011). The hippocampus, neurotrophic factors and depression. CNS Drugs 25, 913-931.
106. Mathers, C. D. and Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3, e442.
107. Meltzer, H., Vostanis, P., Ford, T., Bebbington, P. and Dennis, M. S. (2011). Victims of bullying in childhood and suicide attempts in adulthood. Eur. Psychiatry 26, 498-503.
108. Mikoteit, T., Beck, J., Eckert, A., Hemmeter, U., Brand, S., Bischof, R., Holsboer-Trachsler, E. and Delini-Stula, A. (2014). High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression. Psychopharmacology (Berl.) 231, 2955-2965.
109. Mill, J. and Petronis, A. (2007). Molecular studies of major depressive disorder: the epigenetic perspective. Mol. Psychiatry 12, 799-814.
110. Mitic, M., Simic, I., Djordjevic, J., Radojcic, M. B. and Adzic, M. (2013). Genderspecific effects of fluoxetine on hippocampal glucocorticoid receptor phosphorylation and behavior in chronically stressed rats. Neuropharmacology 70, 100-111.
111. Molendijk, M. L., Bus, B. A. A., Spinhoven, P., Penninx, B. W. J. H., Kenis, G., Prickaerts, J., Voshaar, R. C. O. and Elzinga, B. M. (2011). Serum levels of brainderived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol. Psychiatry 16, 1088-1095.
112. Molendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A. A., Penninx, B. W. J. H. and Elzinga, B. M. (2014). Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484). Mol. Psychiatry 19, 791-800.
113. Monteggia, L. M., Barrot, M., Powell, C. M., Berton, O., Galanis, V., Gemelli, T., Meuth, S., Nagy, A., Greene, R. W. and Nestler, E. J. (2004). Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc. Natl. Acad. Sci. USA 101, 10827-10832.
114. Monteggia, L. M., Luikart, B., Barrot, M., Theobold, D., Malkovska, I., Nef, S., Parada, L. F. and Nestler, E. J. (2007). Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol. Psychiatry 61, 187-197.
115. Mullen, P. E., Martin, J. L., Anderson, J. C., Romans, S. E. and Herbison, G. P. (1996). The long-term impact of the physical, emotional, and sexual abuse of children: a community study. Child Abuse Negl. 20, 7-21.
116. Nelson, E. D., Kavalali, E. T. and Monteggia, L. M. (2008). Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. J. Neurosci. 28, 395-406.
117. Nestler, E. J. and Hyman, S. E. (2010). Animal models of neuropsychiatric disorders. Nat. Neurosci. 13, 1161-1169.
118. Niitsu, T., Fabbri, C., Bentini, F. and Serretti, A. (2013). Pharmacogenetics in major depression: a comprehensive meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 45, 183-194.
119. Onishchenko, N., Karpova, N., Sabri, F., Castrén, E. and Ceccatelli, S. (2008). Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury. J. Neurochem. 106, 1378-1387.
120. Oztan, O., Aydin, C. and Isgor, C. (2011). Chronic variable physical stress during the peripubertal-juvenile period causes differential depressive and anxiogenic effects in the novelty-seeking phenotype: functional implications for hippocampal and amygdalar brain-derived neurotrophic factor and the mossy fibre plasticity. Neuroscience 192, 334-344.
121. Pallavi, P., Sagar, R., Mehta, M., Sharma, S., Subramanium, A., Shamshi, F., Sengupta, U., Qadri, R., Pandey, R. M. and Mukhopadhyay, A. K. (2013). Serum neurotrophic factors in adolescent depression: gender difference and correlation with clinical severity. J. Affect. Disord. 150, 415-423.
122. Park, H. and Poo, M. M. (2013). Neurotrophin regulation of neural circuit development and function. Nat. Rev. Neurosci. 14, 7-23.
123. Piazza, P. V., Deminière, J. M., Le Moal, M. and Simon, H. (1989). Factors that predict individual vulnerability to amphetamine self-administration. Science 245, 1511-1513.
124. Pizarro, J. M., Lumley, L. A., Medina, W., Robison, C. L., Chang, W. E., Alagappan, A., Bah, M. J., Dawood, M. Y., Shah, J. D., Mark, B. et al. (2004). Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice. Brain Res. 1025, 10-20.
125. Pruunsild, P., Kazantseva, A., Aid, T., Palm, K. and Timmusk, T. (2007). Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 90, 397-406.
126. Razafsha, M., Behforuzi, H., Harati, H., Wafai, R. A., Khaku, A., Mondello, S., Gold, M. S. and Kobeissy, F. H. (2013). An updated overview of animal models in neuropsychiatry. Neuroscience 240, 204-218.
127. Reich, C. G., Mihalik, G. R., Iskander, A. N., Seckler, J. C. and Weiss, M. S. (2013). Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity. Neuroscience 253, 444-454.
128. Renthal, W., Maze, I., Krishnan, V., Covington, H. E., III, Xiao, G., Kumar, A., Russo, S. J., Graham, A., Tsankova, N., Kippin, T. E. et al. (2007). Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 56, 517-529.
129. Rojas, P. S., Fritsch, R., Rojas, R. A., Jara, P. and Fiedler, J. L. (2011). Serum brainderived neurotrophic factor and glucocorticoid receptor levels in lymphocytes as markers of antidepressant response in major depressive patients: a pilot study. Psychiatry Res. 189, 239-245.
130. Roth, T. L. and Sweatt, J. D. (2011). Epigenetic marking of the BDNF gene by earlylife adverse experiences. Horm. Behav. 59, 315-320.
131. Roth, T. L., Lubin, F. D., Funk, A. J. and Sweatt, J. D. (2009). Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol. Psychiatry 65, 760-769.
132. Roy, A. and Campbell, M. K. (2013). A unifying framework for depression: bridging the major biological and psychosocial theories through stress. Clin. In est. Med. 36, E170-E190.
133. Russo, S. J., Murrough, J. W., Han, M.-H., Charney, D. S. and Nestler, E. J. (2012). Neurobiology of resilience. Nat. Neurosci. 15, 1475-1484.
134. Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R. et al. (2003). Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 23, 349-357.
135. Sakata, K., Jin, L. and Jha, S. (2010). Lack of promoter IV-driven BDNF transcription results in depression-like behavior. Genes Brain Behav. 9, 712-721.
136. Sales, A. J., Biojone, C., Terceti, M. S., Guimarães, F. S., Gomes, M. V. M. and Joca, S. R. L. (2011). Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors. Br. J. Pharmacol. 164, 1711-1721.
137. Sarchiapone, M., Carli, V., Roy, A., Iacoviello, L., Cuomo, C., Latella, M. C., di Giannantonio, M., Janiri, L., de Gaetano, M. and Janal, M. N. (2008). Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients. Neuropsychobiology 57, 139-145.
138. Sartorius, A., Hellweg, R., Litzke, J., Vogt, M., Dormann, C., Vollmayr, B., Danker-Hopfe, H. and Gass, P. (2009). Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 42, 270-276.
139. Saveanu, R. V. and Nemeroff, C. B. (2012). Etiology of depression: genetic and environmental factors. Psychiatr. Clin. North Am. 35, 51-71.
140. Schroeder, F. A., Lin, C. L., Crusio, W. E. and Akbarian, S. (2007). Antidepressantlike effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol. Psychiatry 62, 55-64.
141. Sen, S., Duman, R. and Sanacora, G. (2008). Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 64, 527-532.
142. Seok, J.-H., Lee, K.-U., Kim, W., Lee, S.-H., Kang, E.-H., Ham, B.-J., Yang, J.-C. and Chae, J.-H. (2012). Impact of early-life stress and resilience on patients with major depressive disorder. Yonsei Med. J. 53, 1093-1098.
143. Sheline, Y. I., Gado, M. H. and Kraemer, H. C. (2003). Untreated depression and hippocampal volume loss. Am. J. Psychiatry 160, 1516-1518.
144. Smalheiser, N. R., Lugli, G., Rizavi, H. S., Torvik, V. I., Turecki, G. and Dwivedi, Y. (2012). MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects. PLoS ONE 7, e33201.
145. Southwick, S. M. and Charney, D. S. (2012). The science of resilience: implications for the prevention and treatment of depression. Science 338, 79-82.
146. Sullivan, P. F., Neale, M. C. and Kendler, K. S. (2000). Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 157, 1552-1562.
147. Tadić, A., Wagner, S., Schlicht, K. F., Peetz, D., Borysenko, L., Dreimüller, N., Hiemke, C. and Lieb, K. (2011). The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 415-420.
148. Taliaz, D., Stall, N., Dar, D. E. and Zangen, A. (2010). Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Mol. Psychiatry 15, 80-92.
149. Taliaz, D., Loya, A., Gersner, R., Haramati, S., Chen, A. and Zangen, A. (2011). Resilience to chronic stress is mediated by hippocampal brain-derived neurotrophic factor. J. Neurosci. 31, 4475-4483.
150. Taliaz, D., Nagaraj, V., Haramati, S., Chen, A. and Zangen, A. (2013). Altered brainderived neurotrophic factor expression in the ventral tegmental area, but not in the hippocampus, is essential for antidepressant-like effects of electroconvulsive therapy. Biol. Psychiatry 74, 305-312.
151. Taylor, P. J., Gooding, P., Wood, A. M. and Tarrier, N. (2011). The role of defeat and entrapment in depression, anxiety, and suicide. Psychol. Bull. 137, 391-420.
152. Tian, F., Hu, X.-Z., Wu, X., Jiang, H., Pan, H., Marini, A. M. and Lipsky, R. H. (2009). Dynamic chromatin remodeling events in hippocampal neurons are associated with NMDA receptor-mediated activation of Bdnf gene promoter 1. J. Neurochem. 109, 1375-1388.
153. Tidey, J. W. and Miczek, K. A. (1997). Acquisition of cocaine self-administration after social stress: role of accumbens dopamine. Psychopharmacology (Berl.) 130, 203-212.
154. Toups, M. S. P., Greer, T. L., Kurian, B. T., Grannemann, B. D., Carmody, T. J., Huebinger, R., Rethorst, C. and Trivedi, M. H. (2011). Effects of serum Brain Derived Neurotrophic Factor on exercise augmentation treatment of depression. J. Psychiatr. Res. 45, 1301-1306.
155. Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J. et al.; STAR∗D Study Team (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR∗D: implications for clinical practice. Am. J. Psychiatry 163, 28-40.
156. Tsai, S. J., Hong, C. J. and Liou, Y. J. (2010). Effects of BDNF polymorphisms on antidepressant action. Psychiatry Investig. 7, 236-242.
157. Tsankova, N. M., Kumar, A. and Nestler, E. J. (2004). Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J. Neurosci. 24, 5603-5610.
158. Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L. and Nestler, E. J. (2006). Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9, 519-525.
159. Uddin, M., Koenen, K. C., Aiello, A. E., Wildman, D. E., de los Santos, R. and Galea, S. (2011). Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample. Psychol. Med. 41, 997-1007.
160. Uher, R., Tansey, K., Rietschel, M., Henigsberg, N., Maier, W., Mors, O., Hauser, J., Placentino, A., Souery, D., Farmer, A. et al.; GENDEP Investigators; MARS Investigators; STAR∗D Investigators (2013). Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies. Am. J. Psychiatry 170, 207-217.
161. Unternaehrer, E., Luers, P., Mill, J., Dempster, E., Meyer, A. H., Staehli, S., Lieb, R., Hellhammer, D. H. and Meinlschmidt, G. (2012). Dynamic changes in DNA methylation of stress-associated genes (OXTR, BDNF ) after acute psychosocial stress. Transl. Psychiatry 2, e150.
162. Vermetten, E., Vythilingam, M., Southwick, S. M., Charney, D. S. and Bremner, J. D. (2003). Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol. Psychiatry 54, 693-702.
163. Vialou, V., Feng, J., Robison, A. J. and Nestler, E. J. (2013). Epigenetic mechanisms of depression and antidepressant action. Annu. Rev. Pharmacol. Toxicol. 53, 59-87.
164. Wang, X.-C., Xu, D.-J., Chen, G.-H., Xia, Q. and Liu, L.-N. (2014). Association of two neurotrophic factor polymorphisms with efficacy of paroxetine in patients with major depressive disorder in a chinese population. Ther. Drug Monit. 36, 612-617.
165. Warden, D., Rush, A. J., Trivedi, M. H., Fava, M. and Wisniewski, S. R. (2007). The STAR∗D Project results: a comprehensive review of findings. Curr. Psychiatry Rep. 9, 449-459.
166. Weaver, I. C. G., Meaney, M. J. and Szyf, M. (2006). Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc. Natl. Acad. Sci. USA 103, 3480-3485.
167. Wilkinson, M. B., Xiao, G., Kumar, A., LaPlant, Q., Renthal, W., Sikder, D., Kodadek, T. J. and Nestler, E. J. (2009). Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J. Neurosci. 29, 7820-7832.
168. Wolkowitz, O. M., Wolf, J., Shelly, W., Rosser, R., Burke, H. M., Lerner, G. K., Reus, V. I., Nelson, J. C., Epel, E. S. and Mellon, S. H. (2011). Serum BDNF levels before treatment predict SSRI response in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1623-1630.
169. Wray, N. R., Pergadia, M. L., Blackwood, D. H. R., Penninx, B. W. J. H., Gordon, S. D., Nyholt, D. R., Ripke, S., MacIntyre, D. J., McGhee, K. A., Maclean, A. W. et al. (2012). Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol. Psychiatry 17, 36-48.
170. Yang, X., Yang, Q., Wang, X., Luo, C., Wan, Y., Li, J., Liu, K., Zhou, M. and Zhang, C. (2014). MicroRNA expression profile and functional analysis reveal that miR-206 is a critical novel gene for the expression of BDNF induced by ketamine. Neuromolecular Med. 16, 594-605.
171. Yasuda, S., Liang, M. H., Marinova, Z., Yahyavi, A. and Chuang, D. M. (2009). The mood stabilizers lithium and valproate selectively activate the promoter IV of brainderived neurotrophic factor in neurons. Mol. Psychiatry 14, 51-59.
172. Zannas, A. S. and West, A. E. (2014). Epigenetics and the regulation of stress vulnerability and resilience. Neuroscience 264, 157-170.
173. Zimmermann, N., Zschocke, J., Perisic, T., Yu, S., Holsboer, F. and Rein, T. (2012). Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels. Biochem. J. 448, 93-102.